This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Cephalotaxus harringtonia
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
Japanese and Chinese conifer containing homoharringtonine, used to develop omacetaxine for chronic myeloid leukemia.
Japanese and Chinese conifer containing homoharringtonine, used to develop omacetaxine for chronic myeloid leukemia. Key active compounds include homoharringtonine, harringtonine, cephalotaxine.
homoharringtonine, along with harringtonine and cephalotaxine, are the primary bioactive compounds in Cephalotaxus harringtonia. These compounds modulates NF-κB and COX-2 inflammatory pathways.
Leukemia treatment via omacetaxine
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anticancer alkaloid research
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-inflammatory
Traditional Chinese medicine use as antitumor herb
Based on traditional use; clinical evidence limited
Used in Japanese folk medicine for fever and pain
Based on traditional use; clinical evidence limited
Found an error or have a correction for Cephalotaxus harringtonia?
Report an Issue →